
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Pilot captures jaw-dropping northern lights show from 36,000 feet (photos) - 2
The Longest Underwater Tunnel Connecting Germany and Denmark - 3
Misinterpretations and Mistakes Portrayed by Hollywood in the General set of laws - 4
French rapper Gims placed under investigation for 'aggravated money laundering' - 5
Instructions to Redo Your Kona SUV for Improved Tasteful Allure and Usefulness
Consumer outlook on UK economy falls to two-year low
Turning into a Distributed Writer: My Composing Process
People who talk with their hands seem more clear and persuasive – new research
Former elite Australian soldier charged with Afghan war crimes
Presenting Nintendo's New Pastel Bliss Con Tones for Switch Gamers: 3 Smart Choices
Strength training is crucial after menopause. How to make the most of your workouts
UN mission says no evidence Hezbollah rearming in southern Lebanon
The 10 Most Significant Virtual Entertainment Missions
Why ordering takeout or calling the dog walker might lead to a happier relationship













